Management of a locally advanced rectal cancer in a patient who declined surgery.
作者信息
Alameddine Raafat, Wehbe David, Weiser Martin, Segal Neil, Goodman Karyn, Shamseddine Ali, Ang Celina, Haydar Ali, Sidani Mustafa, Geara Fady, Naghy Mohamed, O'Reilly Eileen M, Abou-Alfa Ghassan K
机构信息
American University of Beirut Beirut, Lebanon.
出版信息
Gastrointest Cancer Res. 2012 Nov;5(6):205-9.
Abstract
摘要
相似文献
1
Management of a locally advanced rectal cancer in a patient who declined surgery.一名拒绝手术的局部晚期直肠癌患者的治疗
Gastrointest Cancer Res. 2012 Nov;5(6):205-9.
2
Surgery and pre-operative irradiation for locally advanced or recurrent rectal cancer in patients over 75 years of age.75岁以上局部晚期或复发性直肠癌患者的手术及术前放疗
Colorectal Dis. 2006 Mar;8(3):177-85. doi: 10.1111/j.1463-1318.2005.00877.x.
3
Outcomes of pelvic exenteration for locally advanced primary rectal cancer: Overall survival and quality of life.局部晚期原发性直肠癌盆腔廓清术的结果：总生存率和生活质量。
Eur J Surg Oncol. 2016 Jun;42(6):823-8. doi: 10.1016/j.ejso.2016.02.016. Epub 2016 Feb 24.
4
Management of locally advanced primary and recurrent rectal cancer.局部晚期原发性和复发性直肠癌的管理
Clin Colon Rectal Surg. 2007 Aug;20(3):255-63. doi: 10.1055/s-2007-984870.
5
The use of laparoscopy for locally advanced rectal cancer.腹腔镜在局部晚期直肠癌治疗中的应用。
Minerva Chir. 2018 Feb;73(1):77-92. doi: 10.23736/S0026-4733.17.07568-X. Epub 2017 Dec 14.
6
Association of Image-Guided Navigation With Complete Resection Rate in Patients With Locally Advanced Primary and Recurrent Rectal Cancer: A Nonrandomized Controlled Trial.图像引导导航与局部晚期原发性和复发性直肠癌患者完全切除率的相关性：一项非随机对照试验。
JAMA Netw Open. 2020 Jul 1;3(7):e208522. doi: 10.1001/jamanetworkopen.2020.8522.
7
[Efficacy analysis of radiotherapy combined with surgery for locally advanced rectal mucinous adenocarcinoma: a retrospective study based on data of Surveillance, Epidemiology, and End results population].局部晚期直肠黏液腺癌放疗联合手术的疗效分析：一项基于监测、流行病学和最终结果人群数据的回顾性研究
Zhonghua Wei Chang Wai Ke Za Zhi. 2019 Jan 25;22(1):85-93.
8
A comparison of laparoscopic and open surgery following pre-operative chemoradiation therapy for locally advanced lower rectal cancer.术前放化疗后腹腔镜与开放手术治疗局部进展期低位直肠癌的比较。
Jpn J Clin Oncol. 2014 Apr;44(4):305-10. doi: 10.1093/jjco/hyu013. Epub 2014 Mar 3.
9
Outcome after the introduction of a multimodality treatment program for locally advanced rectal cancer.局部晚期直肠癌多模式治疗方案引入后的治疗结果。
Eur J Surg Oncol. 2005 Sep;31(7):727-34. doi: 10.1016/j.ejso.2005.04.009.
10
Upfront radical surgery with total mesorectal excision followed by adjuvant FOLFOX chemotherapy for locally advanced rectal cancer (TME-FOLFOX): an open-label, multicenter, phase II randomized controlled trial.局部进展期直肠癌行全直肠系膜切除术联合辅助 FOLFOX 化疗的 upfront 根治性手术（TME-FOLFOX）：一项开放标签、多中心、二期随机对照临床试验。
Trials. 2020 Apr 7;21(1):320. doi: 10.1186/s13063-020-04266-6.
本文引用的文献
1
Chemoradiotherapy with capecitabine versus fluorouracil for locally advanced rectal cancer: a randomised, multicentre, non-inferiority, phase 3 trial.卡培他滨对比氟尿嘧啶用于局部进展期直肠癌的放化疗：一项随机、多中心、非劣效、III 期临床试验。
Lancet Oncol. 2012 Jun;13(6):579-88. doi: 10.1016/S1470-2045(12)70116-X. Epub 2012 Apr 13.
2
FDG-PET assessment of rectal cancer response to neoadjuvant chemoradiotherapy is not associated with long-term prognosis: a prospective evaluation.氟代脱氧葡萄糖正电子发射断层扫描评估新辅助放化疗后直肠癌的反应与长期预后无关：一项前瞻性评估。
Dis Colon Rectum. 2012 Apr;55(4):378-86. doi: 10.1097/DCR.0b013e318244a666.
3
Four-week neoadjuvant intensity-modulated radiation therapy with concurrent capecitabine and oxaliplatin in locally advanced rectal cancer patients: a validation phase II trial.局部晚期直肠癌患者采用卡培他滨和奥沙利铂同步四周新辅助强度调制放疗的验证性 II 期临床试验。
Int J Radiat Oncol Biol Phys. 2012 Jun 1;83(2):587-93. doi: 10.1016/j.ijrobp.2011.06.2008. Epub 2011 Nov 11.
4
XELOX vs FOLFOX-4 as first-line therapy for metastatic colorectal cancer: NO16966 updated results.XELOX 对比 FOLFOX-4 一线治疗转移性结直肠癌：NO16966 更新结果。
Br J Cancer. 2011 Jun 28;105(1):58-64. doi: 10.1038/bjc.2011.201. Epub 2011 Jun 14.
5
Primary tumor response to preoperative chemoradiation with or without oxaliplatin in locally advanced rectal cancer: pathologic results of the STAR-01 randomized phase III trial.局部进展期直肠癌术前放化疗加或不加奥沙利铂的原发肿瘤反应：STAR-01 随机 III 期临床试验的病理结果。
J Clin Oncol. 2011 Jul 10;29(20):2773-80. doi: 10.1200/JCO.2010.34.4911. Epub 2011 May 23.
6
Recurrence rates and prognostic factors in ypN0 rectal cancer after neoadjuvant chemoradiation and total mesorectal excision.新辅助放化疗和全直肠系膜切除术后 ypN0 直肠肿瘤的复发率和预后因素。
Ann Surg Oncol. 2011 Dec;18(13):3666-72. doi: 10.1245/s10434-011-1788-y. Epub 2011 May 18.
7
Phase III trial assessing bevacizumab in stages II and III carcinoma of the colon: results of NSABP protocol C-08.评估贝伐单抗在 II 期和 III 期结肠癌中的 III 期临床试验：NSABP 方案 C-08 的结果。
J Clin Oncol. 2011 Jan 1;29(1):11-6. doi: 10.1200/JCO.2010.30.0855. Epub 2010 Oct 12.
8
Capecitabine in combination with oxaliplatin or irinotecan in elderly patients with advanced colorectal cancer: results of a randomised phase II study.卡培他滨联合奥沙利铂或伊立替康治疗老年晚期结直肠癌患者：一项随机II期研究结果
Ann Oncol. 2010 Oct;21(10):2121; author reply 2121-2. doi: 10.1093/annonc/mdq450.
9
Capecitabine plus oxaliplatin (XELOX) versus 5-fluorouracil/leucovorin plus oxaliplatin (FOLFOX-6) as first-line treatment for metastatic colorectal cancer.卡培他滨联合奥沙利铂（XELOX）对比 5-氟尿嘧啶/亚叶酸钙联合奥沙利铂（FOLFOX-6）作为转移性结直肠癌一线治疗。
Int J Cancer. 2011 Feb 1;128(3):682-90. doi: 10.1002/ijc.25369.
10
Comparison of two neoadjuvant chemoradiotherapy regimens for locally advanced rectal cancer: results of the phase III trial ACCORD 12/0405-Prodige 2.比较两种局部晚期直肠癌新辅助放化疗方案：ACCORD 12/0405-Prodige 2 期临床试验结果。
J Clin Oncol. 2010 Apr 1;28(10):1638-44. doi: 10.1200/JCO.2009.25.8376. Epub 2010 Mar 1.
Zotero 插件